The in vivo effect of adrenomedullin on rat dural and pial arteries

European Journal of Pharmacology

Volumn 538, Issue 1-3, 2006, Pages 101-107

  Juhl, Louise ^a   Petersen, Kenneth Ahrend ^a   Larsen, Erik Hviid ^b   Jansen Olesen, Inger ^a   Olesen, Jes ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adrenomedullin; Adrenomedullin receptor antagonist; Cerebral blood flow; Middle cerebral artery; Middle meningeal artery; Migraine

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; ADRENOMEDULLIN RECEPTOR ANTAGONIST; ADRENOMEDULLIN[22-52]; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; OLCEGEPANT; PROTEIN DERIVATIVE; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; CIRCULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; DRUG RESPONSE; FEMALE; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PIA ARTERY; PRIORITY JOURNAL; RAT; SWINE;

ADRENOMEDULLIN; ANIMALS; ARTERIES; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DURA MATER; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PEPTIDE FRAGMENTS; PEPTIDES; PIA MATER; PIPERAZINES; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

EID: 33646521719     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.005     Document Type: Article

References (34)

1. Brian Jr. J.E., Faraci F.M., and Heistad D.D. Recent insights into the regulation of cerebral circulation. Clin. Exp. Pharmacol. Physiol. 23 (1996) 449-457
2. Buhlmann N., Leuthauser K., Muff R., Fischer J.A., and Born W. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology 140 (1999) 2883-2890
3. Christopoulos G., Perry K.J., Morfis M., Tilakaratne N., Gao Y., Fraser N.J., Main M.J., Foord S.M., and Sexton P.M. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol. Pharmacol. 56 (1999) 235-242
4. Chu D.Q., Smith D.M., and Brain S.D. Studies of the microvascular effects of adrenomedullin and related peptides. Peptides 22 (2001) 1881-1886
5. Dogan A., Suzuki Y., Koketsu N., Osuka K., Saito K., Takayasu M., Shibuya M., and Yoshida J. Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 17 (1997) 19-25
6. Durham P. CGRP-receptor antagonists-a fresh approach to migraine therapy?. N. Engl. J. Med. (2004) 350
7. Edvinsson L. Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 24 (2004) 611-622
8. Edvinsson L., Alm R., Shaw D., Rutledge R.Z., Koblan K.S., Longmore J., and Kane S.A. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells. Eur. J. Pharmacol. 434 (2002) 49-53
9. Eguchi S., Hirata Y., Iwasaki H., Sato K., Watanabe T.X., Inui T., Nakajima K., Sakakibara S., and Marumo F. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 135 (1994) 2454-2458
10. Faraci F.M., Kadel K.A., and Heistad D.D. Vascular responses of dura mater. Am. J. Physiol. 257 (1989) H157-H161
11. Hattori Y., Nakanishi N., Gross S.S., and Kasai K. Adrenomedullin augments nitric oxide and tetrahydrobioptein synthesis in cytokine-stimulated vascular smooth muscle cells. Cardiovasc. Res. 44 (1999) 207-214
12. Hay D.L., and Smith D.M. Adrenomedullin receptors: molecular identity and function. Peptides 22 (2001) 1753-1763
13. Hay D.L., Howitt S.G., Conner A.C., Doods H., Schindler M., and Poyner D.R. A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells. Br. J. Pharmacol. 137 (2002) 80-86
14. Hay D.L., Howitt S.G., Conner A.C., Schindler M., Smith D.M., and Poyner D.R. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS. Br. J. Pharmacol. 140 (2003) 477-486
15. Hinson J.P., Kapas S., and Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21 (2000) 138-167
16. Juaneda C., Dumont Y., Chabot J.G., Fournier A., and Quirion R. Adrenomedullin receptor binding sites in rat brain and peripheral tissues. Eur. J. Pharmacol. 474 (2003) 165-174
17. Kangawa K., Kitamura K., Minamino N., Eto T., and Matsuo H. Adrenomedullin: a new hypotensive peptide. J. Hypertens., Suppl. 14 (1996) S105-S110
18. Kis B., Abraham C.S., Deli M.A., Kobayashi H., Wada A., Niwa M., Yamashita H., and Ueta Y. Adrenomedullin in the cerebral circulation. Peptides 22 (2001) 1825-1834
19. Kis B., Kaiya H., Nishi R., Deli M.A., Abraham C.S., Yanagita T., Isse T., Gotoh S., Kobayashi H., Wada A., Niwa M., Kangawa K., Greenwood J., Yamashita H., and Ueta Y. Cerebral endothelial cells are a major source of adrenomedullin. J. Neuroendocrinol. 14 (2002) 283-293
20. Kis B., Abraham C.S., Deli M.A., Kobayashi H., Niwa M., Yamashita H., Busija D.W., and Ueta Y. Adrenomedullin, an autocrine mediator of blood-brain barrier function. Hypertens. Res. 26 (2003) S61-S70 (Suppl.)
21. Lang M.G., Paterno R., Faraci F.M., and Heistad D.D. Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles. Stroke 28 (1997) 181-185
22. Lopez J., and Martinez A. Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int. Rev. Cyt. 221 (2002) 1-92
23. Olesen J., Diener H.C., Husstedt I.W., Goadsby P.J., Hall D., Meier U., Pollentier S., and Lesko L.M. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N. Engl. J. Med. 350 (2004) 1104-1110
24. Oliver K.R., Wainwright A., Edvinsson L., Pickard J.D., and Hill R.G. Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J. Cereb. Blood Flow Metab. 22 (2002) 620-629
25. Petersen K.A., Birk S., Doods H., Edvinsson L., and Olesen J. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat. Br. J. Pharmacol. 143 (2004) 697-704
26. Petersen K.A., Dyrby L., Williamson D., Edvinsson L., and Olesen J. Effect of hypotension and carbon dioxide changes in an improved genuine closed cranial window rat model. Cephalalgia 25 (2005) 23-29
27. Petersen K.A., Lassen L.H., Birk S., Lesko L., and Olesen J. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin. Pharmacol. Ther. 77 (2005) 202-213
28. Poyner D.R., Sexton P.M., Marshall I., Smith D.M., Quirion R., Born W., Muff R., Fischer J.A., and Foord S.M. International Union of Pharmacology: XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev. 54 (2002) 233-246
29. Sugo S., Minamino N., Kangawa K., Miyamoto K., Kitamura K., Sakata J., Eto T., and Matsuo H. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem. Biophys. Res. Commun. 201 (1994) 1160-1166
30. Sugo S., Minamino N., Shoji H., Kangawa K., Kitamura K., Eto T., and Matsuo H. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 203 (1994) 719-726
31. Sugo S., Minamino N., Shoji H., Kangawa K., and Matsuo H. Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells. FEBS Lett. 369 (1995) 311-314
32. Verheggen R., Bumann K., and Kaumann A.J. BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP-(8-37). Br. J. Pharmacol. 136 (2002) 120-126
33. Williamson D.J., Hargreaves R.J., Hill R.G., and Shepheard S.L. Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia 17 (1997) 518-524
34. Williamson D.J., Hargreaves R.J., Hill R.G., and Shepheard S.L. Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat-intravital microscope studies. Cephalalgia 17 (1997) 525-531